{
  "id": 6401891,
  "title": "Blackstone explores sale of ZO Skin Health, sources say",
  "url": "https://urgent.news/2026/09/09/blackstone-explores-sale-of-zo-skin-health-sources-say",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-09T09:24:26.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/blackstone-explores-sale-of-zo-skin-health-sources-say-4892512"
  },
  "original_language": "en",
  "account": "Blackstone, the investment firm, is exploring the possibility of selling medical-grade skincare company ZO Skin Health, according to sources. The company is valued at approximately $2 billion in any potential deal, as per individuals familiar with the situation. Blackstone is collaborating with investment banks Citigroup and Raymond James on the sale, which is still in its preliminary stages, according to the sources. The firms have chosen to remain anonymous due to the sensitive nature of the matter. ZO Skin Health, founded by dermatologist Dr. Zein Obagi in 2007, offers a range of skincare products such as cleansers, serums, exfoliators, and toners, which are primarily sold through physicians and skincare professionals. The company's sale process emerges at a time when numerous strategic buyers are focusing on clinically proven, physician-distributed skincare brands like ZO due to their effectiveness and more stable demand compared to over-the-counter products.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}